Carotid atherosclerosis and progression of brain atrophy: The SMART‐MR Study
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Objective: Atherosclerosis has been implicated in the development of brain atrophy. However, support for this association comes from cross‐sectional studies. Methods: Within the Second Manifestations of ARTerial disease‐Magnetic Resonance (SMART‐MR) study, a prospective cohort study among patients with symptomatic atherosclerotic disease (mean age ± standard deviation, 58 ± 10 years; 80% men), magnetic resonance imaging of the brain was performed in 1,232 patients at baseline (2001–2005) and in 663 patients at follow‐up (2006–2009). Brain segmentation was used to quantify total brain volume, cortical gray matter volume, and ventricular volume as indicators of global, cortical, and subcortical atrophy. At baseline, measurements of carotid intima–media thickness (CIMT) and carotid stenosis were performed. Carotid stenosis was classified into groups 0 of 50%, 50 of 70% (moderate), and >70% (severe) and into unilateral or bilateral stenosis. Results: Cross‐sectional regression analyses showed that both increased CIMT and carotid stenosis were associated with decreased relative total brain and cortical gray matter volume. Our prospective findings showed that after a mean follow‐up of 3.9 years (range, 3.0–5.8 years), CIMT and moderate stenosis were not related to progression of brain atrophy. Only severe or bilateral carotid stenosis was related to progression of global atrophy (β [95% confidence interval (CI)], −0.52% [−0.84 to −0.20%], −0.94% [−1.45 to −0.43%]), cortical atrophy (β [95% CI], −0.75% [−1.37 to −0.13%], −1.34% [−2.32 to −0.35%]), and subcortical atrophy (β [95% CI], 0.06% [−0.02 to 0.16%], 0.13% [0.01 to 0.28%]). Interpretation: In a study of patients with atherosclerotic disease with 4 years of follow‐up, only severe or bilateral carotid stenosis, and not moderate carotid stenosis and increased CIMT, were associated with progression of brain atrophy. Ann Neurol 2011;
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977
Review: a gentle introduction to imputation of missing values.
Donders, A. R. T., van der Heijden, G. J. M. G., Stijnen, T., & Moons, K. G. M. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.01.014 · Cited by 2,582
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722
Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560
Vascular risk factors and dementia: How to move forward?
Viswanathan, A., Rocca, W. A., & Tzourio, C. (2009) · Neurology · doi:10.1212/01.wnl.0000341271.90478.8e · Cited by 414
Johnston, S. C., O'Meara, E. S., Manolio, T. A., Lefkowitz, D., O'Leary, D. H., Goldstein, S., Carlson, M. C., Fried, L. P., & Longstreth, W. T. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-4-200402170-00005 · Cited by 304
Manolio, T. A., Burke, G. L., O’Leary, D. H., Evans, G., Beauchamp, N., Knepper, L., & Ward, B. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.2.356 · Cited by 194
Wendell, C. R., Zonderman, A. B., Metter, E. J., Najjar, S. S., & Waldstein, S. R. (2009) · Stroke · doi:10.1161/strokeaha.109.557280 · Cited by 158
Cardiovascular disease and cognitive performance in middle-aged and elderly men
Muller, M., Grobbee, D. E., Aleman, A., Bots, M., & van der Schouw, Y. T. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.005 · Cited by 147
Self-citationKang, S., Wu, Y., & Li, X. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.005 · Cited by 126 · cited 1×
“In fact, studies have shown that CIMT could be reduced by antihypertensive and lipid-lowering treatment.(28,29) However, because CIMT has proven to be a strong predictor of future cardiovascular events,(30) it is unlikely that treatment could have explained the discrepancies between the cross-sectional and prospective…”
Background
Cited by
Impact of Metabolic Syndrome on Cognition and Brain: A Selected Review of the Literature
Yates, K. F., Sweat, V., Yau, P. L., Turchiano, M. M., & Convit, A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.252759 · Cited by 444
Biesbroek, J. M., Kuijf, H. J., van der Graaf, Y., Vincken, K. L., Postma, A., Mali, W. P. T. M., Biessels, G. J., Geerlings, M. I., & on behalf of the SMART Study Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0060541 · Cited by 108
“Baseline characteristics of all patients included in the SMARTMR baseline and follow-up study are extensively described elsewhere [13].”
BackgroundSelf-citationCheng, C.-A., & Chiu, H.-W. (2017) · 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2017.8037381 · Cited by 73
Metadata
- Authors
- Muller, M., van der Graaf, Y., Algra, A., Hendrikse, J., Mali, W. P., & Geerlings, M. I.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2011-06-14
- Volume
- 70
- Issue
- 2
- Pages
- 237-244
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2161965100
- Cited by
- 85
- References
- 11
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carotid atherosclerosis and progression of brain atrophy: The SMART‐MR Study. https://app.cochat.ai/papers/10.1002/ana.22392
- The paper
- Muller, M., van der Graaf, Y., Algra, A., Hendrikse, J., Mali, W. P., & Geerlings, M. I. (2011). Carotid atherosclerosis and progression of brain atrophy: The SMART‐MR Study. Annals of Neurology. https://doi.org/10.1002/ana.22392
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.